Literature DB >> 29851927

Enasidenib for relapsed/refractory acute myeloid leukemia with IDH2 mutations: optimizing the patient experience.

Gail J Roboz1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29851927

Source DB:  PubMed          Journal:  Clin Adv Hematol Oncol        ISSN: 1543-0790


× No keyword cloud information.
  1 in total

1.  Development and Validation of UPLC-MS/MS Method for Determination of Enasidenib in Rat Plasma and Its Pharmacokinetic Application.

Authors:  Shuang-Long Li; Yong-Liang Zhu; Yi Zhang; Shu-Han Liu; Xiang-Die Wang; Xiang-Jun Qiu
Journal:  Int J Anal Chem       Date:  2020-03-31       Impact factor: 1.885

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.